8:15am ET
Health and Healthcare
Short Sellers Take Mixed Stance on Major Pharma
The May 13 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
Companies
/Healthcare
Abbvie Inc
$255.48
▼ $2.67 (−1.03%) today
Markets closed · 1:32pm ET
ABBV Coverage
Page 347:40am ET
Health and Healthcare
ASCO Could Make or Break These 7 Cancer Drug Trials
The king of biotech and pharma events is about to take place. The 2016 annual meeting of the American Society of Clinical Oncology (ASCO) is set to run from June 3 to…
8:45am ET
Health and Healthcare
Major Pharma Short Interest Continues to Recede
The short interest data have been released for the April 29 settlement date, and for most of the selected pharmaceutical stocks short interest decreased.
7:35am ET
Health and Healthcare
3 Big Pharma Stocks With Credible Threats to Their Blockbusters
A pharmaceutical company could face a threat to one of its products for a number of reasons, ranging from an improved formulation to a patent expiry and the opening of the floodgates…
9:10am ET
Health and Healthcare
Why AbbVie Earnings Failed to Impress Investors
AbbVie reported its first-quarter financial results and guidance before the markets opened on Thursday.
Chris Lange 9:15am ET
Health and Healthcare
Major Pharma Short Interest Remains Mixed, With 1 Massive Drop
The April 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest was mixed.
6:57am ET
Special Report
The World’s 15 Top Selling Drugs
Attaining a certain drug can mean the difference between life and death for millions of Americans. These essential products also help generate billions for drug manufacturers. Pharmaceutical companies generate an estimated $300…
8:25am ET
Investing
2 Cheap Pharmaceuticals Highlight Jefferies Franchise Picks Dividend Stocks to Buy
These four Jefferies Franchise Picks are rated Buy and pay the highest dividends. They make good sense for investors now.
9:50am ET
Health and Healthcare
Short Sellers Become More Selective in Major Pharma
The March 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest was mixed.
8:35am ET
Investing
4 Jefferies Franchise Picks With Big Dividends Are Solid Q2 Buys
Now all investor eyes turn to first-quarter earnings results. With interest rates still very low, investors looking to add capital should still focus on top dividend-paying stocks.
11:05am ET
Health and Healthcare
Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts
Long-term growth investors looking for a degree of safety and value should consider some of these outstanding companies. While the sentiment may be less than stellar now, massive drug pricing changes anytime…
9:25am ET
Health and Healthcare
Jefferies Top Drug Stocks for the Rest of 2016
For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made a couple additions and updated its price target information.
8:40am ET
Health and Healthcare
Major Pharma Short Interest Takes a Small Step Back
The February 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest decreased.
10:10am ET
Investing
Large Cap Blue Chips Dominate Jefferies Top Value Stocks to Buy
In a recent research report, Jefferiesfocused on some large cap stocks that are still trading way below their 52-week highs.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Enbridge, Micron, Sun Life, Starbucks, Stratasys, Wynn and Many More
The top analyst upgrades, downgrades and initiations seen from Monday, March 7, include Enbridge, Micron Technology, Sun Life Financial, Starbucks, Stratasys and Wynn Resorts.
